Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07216456 · ClinicalTrials.gov registry record · NA
Vaginal Dilator Therapy After Pelvic Radiation
A NA study, sponsored by Duke University.
- Not yet
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT07216456 is a NA study that has not yet begun recruiting, run by Duke University. The registered enrollment target is 88 participants.
The verdict
NCT07216456, a NA study, has not yet begun recruiting, sponsored by Duke University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
This study is testing a new program to help women who have had pelvic radiation therapy to use vaginal dilators more regularly. Vaginal dilators are important tools that can help prevent or treat vaginal narrowing (called vaginal stenosis), which can happen after radiation and make medical exams or sexual activity painful or difficult. Even though dilators are recommended, many women don't use them as often as needed. In this study, 88 participants will be randomly assigned to one of two groups: * One group will receive the new behavioral program, which includes support and strategies to help with regular dilator use. * The other group will receive written educational materials (enhanced usual care). The study will look at how often and how long participants use their dilators, and whether the program helps reduce symptoms like pain or emotional distress. Participants will complete surveys at the beginning of the study and again at 3, 6, and 9 months, plus short monthly check-ins. The goal is to see if the program is helpful and easy to use, and to prepare for a larger study in the future.
Interventions
- BEHAVIORAL Improving Engagement with Vaginal Dilator Therapy after Pelvic Radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2027-08-01 |
| Est. Completion | 2030-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07216456
The ClinicalTrials.gov registry entry for NCT07216456 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Improving Engagement with Vaginal Dilator Therapy after Pelvic Radiation is the first listed.
NCT07216456 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07216456 about?
NCT07216456 is a clinical study titled "Vaginal Dilator Therapy After Pelvic Radiation". This study is testing a new program to help women who have had pelvic radiation therapy to use vaginal dilators more regularly. Vaginal dilators are important tools that can help prevent or treat vaginal narrowing (called vaginal stenosis), which can happen after radiation and make medical exams or ...
What is the current status of trial NCT07216456?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 88 participants. The study started on 2027-08-01. Estimated completion is 2030-04-30.
What interventions are being tested in trial NCT07216456?
The interventions under investigation include: Improving Engagement with Vaginal Dilator Therapy after Pelvic Radiation (BEHAVIORAL).
Who is sponsoring clinical trial NCT07216456?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.